Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Éditorial
Chronique Mon C**
Alain Lesage, Raymond Morissette
(PDF)

Editorial
Chronic My A**
Alain Lesage, Raymond Morissette
(PDF)

En Revue
Réadaptation Psychiatrique en Milieu Francophone : Pratiques Actuelles, Défis Futurs
Raymond Tempier, Jérôme Favrod
(PDF)

In Review
Rehabilitation in the United Kingdom: Research, Policy, and Practice
Frank Holloway, Jerome Carson, Sarah Davis

(PDF)

Review Papers
Breaking the Myths: New Treatment Approaches for Chronic Depression

Erin E Michalak, Raymond W Lam

(PDF)

Mental Health Reform and Evolution of General Psychiatry In Ontario
John Robert Swenson, Jacques Bradwejn

(PDF)

Original Research
Mental Retardation in Teenagers: Prevalence Data From the Niagara Region, Ontario

Elspeth A Bradley, Ann Thompson, Susan E Bryson

(PDF)

Treatment-Seeking Rates and Associated Mediating Factors Among Individuals With Depression
Kristin Bristow, Scott Patten

(PDF)

Brief Communication
Proton Magnetic Resonance Spectroscopy of the Hippocampus and Occipital White Matter in PTSD: Preliminary Results

Gerardo Villarreal, Helen Petropoulos, Derek A Hamilton, Laura M Rowland, William P Horan, Jacqueline A Griego, Margaret Moreshead, Blaine L Hart, William M Brooks

(PDF)

Risperidone Decreases Craving and Relapses in Individuals with Schizophrenia and Cocaine Dependence
David A Smelson, Miklos F Losonczy, Craig W Davis, Maureen Kaune, John Williams, Douglas Ziedonis

(PDF)


CPA Position Paper
The Duty to Protect


APC Énoncé de principe de l’APC
Le devoir de protection


Book Reviews
(PDF)
Hidden Faults: Recognizing and Resolving Therapeutic Disjunctions.

The New Oxford Textbook of Psychiatry

Unfree Associations: Inside Psychoanalytic Institutes

Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy

Forensic Psychiatric Evidence


Letters to the Editor
(PDF)
Catastrophic Reactions Induced by Tetrabenazine

Olanzapine: A Proarrhythmic Drug?

Respiratory Symptoms in Nocturnal Panic Attacks

Carbon Dioxide Test in Respiratory Panic Disorder Subtype

Depression in Multiple Sclerosis Associated With Interferon Beta-1a (Rebif)

Atypical Antipsychotics and Glycemia: A Case Report

Olecranon Bursitis as a Complication of Tardive Dyskinesia

Letters to the Editor

Carbon Dioxide Test in Respiratory Panic Disorder Subtype

Dear Editor:

Inhaling high concentrations of carbon dioxide (CO2) has consistently been shown to provoke panic attacks in patients with panic disorder (PD) (1). Our objective was to verify the sensitivity to CO2 challenge of PD patients with respiratory and nonrespiratory subtypes. We randomly selected 20 PD patients (diagnosed according to DSM-IV criteria) at the Laboratory of Panic and Respiration in Rio de Janeiro. The subjects signed a voluntary written inform consent, and the protocol was approved by our local ethical committee.

To participate, we required the subjects to be at least 18 years old, to report at least 3 panic attacks in the last 2 weeks, and to be free of psychotropic drugs for at least 1 week. Exclusion criteria were any other current mental or major medical disorders, pregnancy, and substance abuse within the prior 6 months. We assessed the clinical symptoms of the most severe recent panic attack before the initial test to classify the subjects as respiratory and nonrespiratory subtypes (2).

The test was double-blind, and 2 mixtures were used: 1) 35% CO2 and 65% O2, and 2) 100% atmospheric compressed air, given 20 minutes apart. Participants were asked to exhale as fully as possible, place the mask on their face, and take a fast, vital-capacity breath, inhaling either the 35% CO2 mixture or the atmospheric compressed air. They were asked to hold their breath for 8 seconds. Immediately after, they were asked to repeat the fast, vital-capacity breath and hold it again for 8 seconds. After 20 minutes, this test was repeated with the other gas mixture. We repeated the tests in 2 weeks. During that time, no participants received any psychotropic drugs.

We defined a CO2-induced panic attack as follows: 1) 4 or more DSM-IV panic attack symptoms, 2) at least 1 DSM-IV cognitive symptom (for example, fear of dying or losing control), 3) the sensation of a spontaneous panic attack, and 4) agreement of 2 investigators. To compare the differences between the presence of panic attacks after CO2 challenge, we used Fisher’s exact test.

The patients were 12 women and 8 men with a mean (SD) age of 35.8 (6.9) years. In the respiratory subtype there were 6 women and 5 men with a mean (SD) age of 33.4 (9.8) years, and in the nonrespiratory subtype there were 6 women and 3 men with a mean (SD) age of 37.8 (4.3) years. There was no difference between the 2 groups in mean age (t-test, P = 0.677).

In the first CO2 challenge test, 7/11 (63.6%) respiratory PD patients and 3/9 (33.3%) nonrespiratory PD patients had a panic attack (Fisher’s exact test, P = 0.024). In the second CO2 challenge (after 2 weeks), 9/11 (81.8%) respiratory PD patients and 3/9 (33.3%) nonrespiratory PD patients had a panic attack (Fisher’s exact test, P = 0.011). No patient had a panic attack with atmospheric air.

Our results are similar to those of Biber and Alkin (1). Klein’s theory (3) could explain why the respiratory panic subtype patients had higher rates of panic attacks than those of the nonrespiratory subtype, indicating greater sensitivity to CO2. The characterization of PD subtypes through CO2 challenge may be useful in elucidating the biological features, course, and response to treatment of PD.

References

1. Biber B, Alkin T. Panic disorder subtypes: differential responses to CO2 challenge. Am J Psychiatry 1999;156:739–44.

2. Briggs AC, Stretch DD, Brandon S. Subtyping of panic disorder by symptom profile. Br J Psychiatry 1993;163:201–9.

3. Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 1993;50:306–17.

Antonio E Nardi , MD
Alexandre M. Valença , MD
Isabella Nascimento , MD
Walter A Zin, MD
Márcio Versiani, MD
Rio de Janeiro, Brazil





CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2001 | Index RCP des auteurs 2001
Subject Index to 2001 | Index RCP des sujets 2001
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil